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ABSTRACT
Hematopoietic stem cells (HSC) self-renewal takes place in the same microenvironment in which massive hematopoietic progenitor
proliferation, commitment, and differentiationwill occur. This is onlymade possible if the bonemarrowmicroenvironment comprises different
speciﬁc niches, composed by different stromal cells that work in harmony to regulate all the steps of the hematopoiesis cascade. Histological
and functional assays indicated that HSC and multipotent progenitors preferentially colonize the endosteal and subendosteal regions, in close
association with the bone surface. Conversely, committed progenitors and differentiated cells are distributed in the central and perisinusoidal
regions, respectively. Over the last decade, many investigative teams sought to deﬁne which cell types regulate the HSC niche, how they are
organized, and to what extent they interface with each other. System dynamics requires different stromal cells to operate distinct functions
over similar HSC pools rather than a single stromal cell type controlling everything. Therefore, our focus herein is to depict the players in the
endosteal and subendosteal regions, named the endosteal niche, a necessary step to better understand the interactions of the HSC within
the niche and to identify potential targets to manipulate and/or modulate normal and malignant HSC behavior. J. Cell. Biochem. 116: 6–11,
2015. © 2014 Wiley Periodicals, Inc.
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After birth, the bone marrow becomes the main site of bloodcells production and hematopoietic stem cells maintenance
for the individual0s lifetime. Less than 0.5 percent of all nucleated
cells in the bone marrow are hematopoietic stem cells (HSC)
[Morrison et al., 1995; Seraﬁni et al., 2007; Oguro et al., 2013].
Interestingly, HSC self-renewal takes place in the same micro-
environment in which massive hematopoietic progenitor prolif-
eration, commitment, and differentiation will occur. This is only
made possible if the bone marrow microenvironment comprises
different speciﬁc niches, composed by different stromal cells that
work in harmony to regulate all the steps of the hematopoiesis
cascade. Over the last decade, many investigative teams sought to
deﬁne which cell types regulate the HSC niche, how they are
organized, and to what extent they interface with each other.
System dynamics requires different stromal cells to operate
distinct functions over similar HSC pools rather than a single
stromal cell type controlling everything. Therefore, our focus
herein is to depict the players in the endosteal and subendosteal
regions, a niche in which most of the HSC reside.
NOT TOO FAR FROM THE SURFACE
One of the ﬁrst in vivo assays designed to determine the existence of
hematopoietic progenitors in a given population was counting the
numbers of colonies in the spleen 8–12 days after transplantation
[Siminovitch et al., 1963; Till and McCulloch, 1963; Till et al., 1964].
When injected into the peripheral blood of lethally irradiated
animals, a few hematopoietic progenitors migrate and colonize the
spleen, in which they proliferate and give rise to colonies that can be
observed visually. These progenitors, which we now know as short-
term hematopoietic stem cells, were identiﬁed as Colony-Forming
Units-Spleen (CFU-S). A careful analysis of the colonies showed that
progenitors proliferate and mature to fully differentiated normal
cells. Ray Schoﬁeld (1978) questioned that the spleen connective
tissue cells would then create the conditions to support a continued
proliferation of these progenitors. This observation led him to
hypothesize that progenitors/stem cells in the tissue would dwell in
speciﬁc niches created by permissive stroma cells, which play crucial
roles on the stem cells behavior. Cell behavior, in vivo and in vitro,
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regardless its differentiation stage, is the result of a balance between
intrinsic (gene expression) and extrinsic (niche) factors. To reside in a
niche created by a speciﬁc stroma, hematopoietic cells must carry the
adequate apparatus in order respond to the niche signals. Failing to
express the right tools might result in an extremely different and
unexpected behavior.
Almost all non-hematopoietic cells in the bone marrow micro-
environment—osteoblasts, reticular cells, ﬁbroblasts, neurons,
adipocytes, endothelial cells—can be identiﬁed as a member of the
stromal category and may play a critical role in hematopoiesis.
Nonetheless, each stromal cell type likely resides in a distinct
anatomical area in the marrow cavity, or in unique combination, to
create different niches compatible to the intricate dynamic of the
hematopoietic system. Long-term hematopoietic stem cells self-
renewal and committed progenitors proliferation and differentiation
take place in the same microenvironment, but in very distinct
niches – organized by distinct stromal cell types at different
anatomical positions [Lord et al., 1975; Lambertsen andWeiss, 1984;
Taichman and Emerson, 1994; Calvi et al., 2003; Zhang et al., 2003;
Taichman et al., 1996, 2010; Balduino et al., 2005, 2012; Ding et al.,
2012]. In a magniﬁed view of the niche, even hematopoietic stem
cells might require distinctive and/or combined interactions with
similar albeit different stromal cell types regarding their quiescent or
proliferative state.
How hematopoietic stem cells integrate cell intrinsic or extrinsic
signals to remain quiescent, to self-renew, or to undergo differ-
entiation remains unknown. Although several studies using genetic
manipulated animals generate very rich data and demonstrate the
contribution of very important molecules over hematopoietic stem
cell behavior, they frequently fail to consider different stromal cell
types, or even what the loss of a single cell type has on the other
hematopoietic stroma, in such a deﬁned niche.
The hematopoietic system is well organized in a hierarchical
differentiation cascade [Seita and Weissman, 2010]. Long-term HSC
originate short-term HSC, which then undergoes several commit-
ments and massive proliferation, until reaching full differentiation.
Each step in this cascade demands a different combination of
cytokines, chemokines, extracellular matrix interactions and cell-
cell interactions, which are offered by different stromal cell types
[Lord et al., 1975; Lambertsen and Weiss, 1984; Taichman and
Emerson, 1994; Calvi et al., 2003; Zhang et al., 2003; Arai et al.,
2004; Stier et al., 2005; Sugiyama et al., 2006; Taichman et al., 1996,
2010; Balduino et al., 2005, 2012; Ding et al., 2012]. The notion that
different niches compose the bone marrow microenvironment was
envisioned by Lord and colleagues [Lord et al., 1975]. In accordance
with these data, another study has proposed that bonemarrow cavity
could be subdivided into at least four niches (Fig. 1): endosteal,
subendosteal, central, and perisinusoidal [Lord et al., 1975;
Lambertsen and Weiss, 1984]. Histological and functional assays
indicated that HSC and multipotent progenitors preferentially
colonize the endosteal and subendosteal regions, in close association
with the bone surface. Conversely, committed progenitors and
differentiated cells are distributed in the central and perisinusoidal
regions, respectively [Lord et al., 1975; Lambertsen andWeiss, 1984;
Taichman and Emerson, 1994; Nilsson et al., 2001; Arai et al., 2004;
Kiel et al., 2005; Jung et al., 2006; Lo Celso et al., 2009].
Long-term and short-term HSC, as well as committed progenitors
are easily identiﬁed by the expression of set of speciﬁc surface
markers [Logan et al., 2012; Oguro et al., 2013]. Under physiological
conditions, 20%–30%of the HSC are in a quiescent stage, and studies
Fig. 1. Model of the bone marrow microenvironment subdivision as proposed by Lambertsen and Weiss [Lambertsen and Weiss, 1984]. Endosteal and subendosteal regions
compose the endosteal niche, which harbors both the proliferative and quiescent HSC niches. This organization is easily adapted to the cavity of a long bone shaft, but a few
anatomical arrangements must be considered when analyzing the bone marrow in the trabecular bone.
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have shown that these slow-cycling HSC are found in association
with endosteal osteoblasts [Kiel et al., 2005; Lo Celso et al., 2009;
Nombela-Arrieta et al., 2013]. In in-vivo myelosuppressive models,
HSC residing in contact with endosteal osteoblasts are preserved
[Arai et al., 2004; Kiel et al., 2007]. Conversely, most of the fast-
cycling HSC are found in the perivascular neighborhood of the blood
vessels distributed in the subendosteal region [Sugiyama et al., 2006;
Kiel et al., 2007], and most of them are ablated in in-vivo
myelosuppressive models.
The role of endosteal osteoblasts on the HSC maintenance and
self-renewal was ﬁrst proposed in vitro by Taichman and Emerson
[1998], [Taichman and Emerson, 1994; Taichman et al., 1996] and
later in vivo was established by others [Calvi et al., 2003; Zhang
et al., 2003; Visnjic et al., 2004]. In transgenic animals, increased or
decreased numbers of osteoblasts results in increased or decreased
numbers of long-term HSC, respectively, without affecting any of
the others hematopoietic categories in the bone marrow [Calvi et al.,
2003; Zhang et al., 2003; Kuznetsov et al., 2004; Visnjic et al., 2004].
This is evidence that osteoblasts play a crucial role in HSC
maintenance and behavior. Lambertsen and Weiss (1984) showed
that most of the perivascular niches harboring HSC are distributed in
the subendosteal region. In this perivascular niche [Arai et al., 2004;
Kiel et al., 2005; Sugiyama et al., 2006], HSC reside on the abluminal
side of bone marrow sinusoids, and are supported by the endothelial
and perivascular reticular/mesenchymal cells. These perivascular
stromal cells express high levels of CXCL12, a chemokine required
for HSCmaintenance and lodging [Jung et al., 2006; Sugiyama et al.,
2006]. Most of the cells creating the proliferative niche express
CXCL12. In-situ observation demonstrated that most of hemato-
poietic stem cells are concentrated in the trabecular zone of the
marrow cavity, which also harbors high numbers of niche osteblasts,
sinusoids, and CXCL12-positive reticular cells. Nonetheless, HSC
maintenance by both endosteal and perivascular niches are, at least
in part, mediated by Jagged–Notch and angiopoietin-1-Tie2
interactions [Calvi et al., 2003; Zhang et al., 2003; Arai et al.,
2004; Sugiyama et al., 2006].
With direct or indirect contributions from osteoblasts and
perivascular cells, published data support the fact that both
proliferative and quiescent niches coexist in the marrow cavity
and might even interact [Calvi et al., 2003; Zhang et al., 2003;
Balduino et al., 2005; Wilson and Trumpp, 2006; Parmar et al., 2007;
Taichman et al., 2010]. Endosteal bone-lining cells, at least most of
them, are fully committed osteoblasts, as demonstrated by in vitro
and in vivo assays [Balduino et al., 2005, 2012; Taichman et al.,
2010]. In an intimate interaction with the endosteal cells, 2–3 layers
of reticular/noncommitted mesenchymal cells will occupy the
subendosteal region. Two very distinct stromal populations
[Balduino et al., 2005, 2012; Taichman et al., 2010] that, due to
their close range, are usually identiﬁed as in one niche. Our main
purpose is to draw reader0s attention to the fact that endosteal and
subendosteal stromal derived cells can no longer be identiﬁed as a
common stroma from a singular endosteal niche. The two regions—
endosteal and subendosteal—can be considered as part of one niche,
but stroma from this niche is far from being singular.
The cellular fraction of the endosteum is enriched in fully
committed osteoblasts spread along the inner bone surface. These
osteoblasts and all cells from the “reticular” fraction derive from a
common progenitor, named mesenchymal stem cell, which is known
to colonize the bone marrow during osteogenesis as blood vessels
invade the cartilage mold [Nakamura et al., 2010]. Data from our
group and others [Taichman, 2005; Nakamura-Ishizu and Suda,
2013; Morrison and Scadden, 2014] suggest that at least three types
of stromal cells can be identiﬁed in the niche: osteoblasts,
subendosteal perivascular reticular cells, and subendosteal non-
perivascular reticular cells, each of which play distinct roles on
hematopoietic stem cells behavior and niche creation, and must be
considered as well. These cells share a few markers [Nakamura et al.,
2010], mostly regarding the osteogenic lineage, which may not
reﬂect the real effect of speciﬁc factors due to stromal population
overlapping when studying genetically manipulated animals.
Regardless their origins, stromal cells engaged in the osteogenic
differentiation cascade express Runx2 [Ducy et al., 1997; Komori
et al., 1997; Stein et al., 2004]. This transcription factor is a member
of the runt homology domain family and its function is essential to
skeletogenesis, whereas in its absence no hyperthrophic chondro-
cytes and osteoblasts are generated during embryo development
[Komori et al., 1997]. Runx2 was once indicated as skeletal tissue
master gene. However, different transcription factors, extracellular
matrix proteins and surface molecules will be necessary to complete
the whole differentiation cascade. Close to the bone surface, all
endosteal cells in the monolayer express Runx2. It is expected that
cells in the subendosteal region also express Runx2, except
perivascular progenitors.
The second step towards the osteogenic lineage is the expression
of Osterix (also known as Sp7), another very important transcription
factor, which is genetically downstream of the Runx2 [Ducy et al.,
1997]. Osterix is expressed not only by osteogenic cells, but also pre-
hypertrophic chondrocytes and a subset of stromal cells. Its
expression is also essential to the osteogenic differentiation, whereas
Osx-null mice lack bone tissue. In Osx-null mice, the expression of
Runx2 is maintained, but the expression of other osteoblast speciﬁc
markers is dramatically reduced or even undetected [Nakashima
et al., 2002]. In these animals, osteogenesis is not completed since
mesenchymal cells are unable to differentiate osteblasts. Osxþ cells
are considered pre-osteoblasts and they begin to express a set of
osteogenic markers, mostly related to extracellular matrix [Naka-
shima et al., 2002]. Among the markers, Collagen I (Col1a1),
Osteopontin (Opn), Bone Sialoprotein (BSP), and Alkaline Phospha-
tase (ALP) are detected.
Most Osterix positive cells in bone marrow are endosteal
osteoblasts and subendosteal pre-osteoblasts [Nakashima et al.,
2002]. There is a subpopulation of Osxþ cells that also expresses
CXCL12/Stromal-Derived Factor-1 (SDF-1), which is crucial to HSC
homing and lodging in the bonemarrow cavity. Jung and colleagues
[Jung et al., 2006] demonstrated in vitro that SDF-1 is secreted early
in differentiation and gradually ceases as osteoblasts become
mature. Greenbaum and colleagues (2013) and attempted to
establish the role of different niches in the matter of SDF-1 secretion
by the stromal population. SDF-1 gene selectively silenced in Osxþ
cells resulted in no signiﬁcant changes in HSC frequency, as
determined by both phenotypical and functional assays [Greenbaum
et al., 2013]. However, hematopoietic progenitor cells retention in
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marrow was reduced, as CFU-C (Colony Forming Units in Culture) in
blood and spleen increased in 10 and 8 fold higher, respectively
[Greenbaum et al., 2013].
As pre-osteoblasts move forward in the differentiation path to
mature osteoblasts, matrix protein synthesis is intensiﬁed. Osteo-
calcin is expressed by mature osteoblasts, which also express high
levels of Collagen I (Col1a1), Osteopontin (Opn), Bone Sialoprotein
(BSP), and Alkaline Phosphatase (ALP) [Aubin et al., 1995; Aubin,
1998]. Several surface markers, such as CD44, CD90, and ALCAM
[Nakamura et al., 2010; Chitteti et al., 2013], and other molecular
markers [Kiel et al., 2009; Greenbaum et al., 2013] have been used
separately or in combination to fractionate subpopulations and to
identify the hierarchical organization of the osteogenic lineage, or
even their contributions to the hematopoiesis [Chitteti et al., 2010,
2014; Cheng et al., 2011], but still need some reﬁnements.
Several in vivo models using genetically manipulated animals
have been used to identify the contribution of different stromal cell
types to HSC niche formation. However, so far, no speciﬁc marker
has been credited the capacity to target one speciﬁc stromal
population. From perivascular stem cells to differentiated osteo-
blasts, no describedmarker can be used to target one speciﬁc stromal
population in the niche. However, stromal cells differences in this
small ranged niche must not be ignored. Anatomical organization of
the niche still is a very useful parameter.
CONCLUDING REMARKS
Current evidence supports the existence of two niches to harbor
long-term HSC, referred as to “proliferative niche” and “quiescent
niche” [Calvi et al., 2003; Zhang et al., 2003; Balduino et al., 2005;
Wilson and Trumpp, 2006; Parmar et al., 2007; Taichman et al.,
2010]. These niches comprise the perivascular cells and endosteal
osteoblasts, respectively, and most of the data generated are based
on HSC cell behavior, as they present the same phenotype in both
niches in vivo. Although these two niches are usually discussed
somehow disconnectedly, how far from each other are they in vivo?
Apparently, blood vessels in the subendosteal region (perivascular
niche) interfacewith the endosteal osteoblasts, leading to an idea of a
multicellular niche rather than a single cell responsible for
maintaining HSC. At some point, in the perivascular niche, HSC,
at least part of them, will interact with perivascular cells and
osteoblasts at the same time (Fig. 2). Besides, stromal cells residing
neither in the perivascular niche nor on the bone surface must not be
discarded, as they occupy a great extent of the subendosteal region.
Due to lack of speciﬁc markers to identify and categorize the
stroma in this region, anatomical organization is very useful to
better understand the interactions of the HSC within the niche and
the identiﬁcation of potential targets to manipulate and/or modulate
HSC behavior. Besides, stromal cells in the endosteal niche may no
longer be considered as a single “the endosteal stroma,” as this will
lead to misconception of what and how each cell contributes to the
niche formation. Moreover, as HSC niche may also provide signals
to support certain malignancies, to know the exact contributions
from different stromal parties will be a way to identify targets
and cure.
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